Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity

Boyle, 1990, Epidemiology of mouth cancer in 1989: a review, J R Soc Med, 83, 724, 10.1177/014107689008301116

Field, 1992, Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck, Oral Oncol, Eur J Cancer, 28B, 67, 10.1016/0964-1955(92)90016-T

Field, 1992, Overexpression of the p53 gene in head and neck cancer, linked with heavy smoking and drinking, Lancet, 339, 502, 10.1016/0140-6736(92)91122-O

Brennan, 1995, Molecular assessment of histopathological staging in squamous cell carcinoma of the head and neck, N Engl J Med, 332, 429, 10.1056/NEJM199502163320704

Tsujimoto, 1985, The t(14;18) chromosome translocations involved in B-cell neoplasms results from mistakes in VDJ joining, Science, 299, 1390, 10.1126/science.3929382

Cleary, 1986, Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation, Cell, 47, 19, 10.1016/0092-8674(86)90362-4

Pezzella, 1990, The 14;18 translocation European cases of follicular lymphoma: comparison of Southern blotting and polymerase chain reaction, Br J Haematol, 76, 58, 10.1111/j.1365-2141.1990.tb07836.x

Aisenberg, 1988, The bcl-2 gene is rearranged in many diffuse B-cell lymphomas, Blood, 71, 969, 10.1182/blood.V71.4.969.969

Tsujimoto, 1986, Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma, 83, 5214

Hockenbery, 1990, Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death, Nature, 348, 334, 10.1038/348334a0

Hockenbery, 1991, bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death, 88, 6961

Lu, 1993, bcl-2 Expression in adult and embryonic non-haematopoietic tissues, J Pathol, 169, 431, 10.1002/path.1711690408

Pilotti, 1994, bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland, J Pathol, 172, 337, 10.1002/path.1711720408

Ikegaki, 1994, Expression of bcl-2 in small cell lung carcinoma cells, Cancer Res, 54, 6

Leek RD, Kaklamanis L, Pezzella F, Gatter KC, Harris AL. bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br J Cancer 1004, 69, 135–139.

Lu, 1993, bcl-2 proto-oncogene expression in Epstein-Barr virus-associated nasopharyngeal carcinoma, Int J Cancer, 53, 29, 10.1002/ijc.2910530107

Pezzella, 1993, bcl-2 protein in non-small-cell lung carcinoma, N Engl J Med, 329, 690, 10.1056/NEJM199309023291003

Yunis, 1989, bcl-2 and other genomic alterations in the prognosis of large cell lymphomas, N Engl J Med, 320, 1047, 10.1056/NEJM198904203201605

McDonnell, 1992, Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer, Cancer Res, 52, 6940

Campos, 1993, High expression of bcl-2 in acute myeloid leukemia cells is associated with poor response to chemotherapy, Blood, 18, 3091, 10.1182/blood.V81.11.3091.3091

Krajewski, 1994, Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl-2, Am J Pathol, 145, 1323

Oltvai, 1993, bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death, Cell, 74, 609, 10.1016/0092-8674(93)90509-O

Wahl, 1971, 17

Norton, 1994, Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues, J Pathol, 173, 371, 10.1002/path.1711730413

Hsu, 1981, Use of avidin—biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures, J Histochem Cytochem, 29, 577, 10.1177/29.4.6166661

Nakagawa, 1994, bcl-2 expression in epidermal keratinocytic diseases, Cancer, 74, 1720, 10.1002/1097-0142(19940915)74:6<1720::AID-CNCR2820740613>3.0.CO;2-T

Korsmeyer, 1992, bcl-2 initiates a new category of oncogenes: regulators of cell death, Blood, 80, 879, 10.1182/blood.V80.4.879.879

Pezzella, 1990, Expression of the bcl-2 oncogene protein is not specific for the 14; 18 chromosomal translocation, Am J Pathol, 137, 225

Ramsay, 1995, bcl-2 protein expression in melanocytic neoplasms of the skin, Modern Pathol, 2, 150

Pezzella, 1993, bcl-2 protein in non-small-cell lung, N Engl J Med, 329, 690, 10.1056/NEJM199309023291003

Castle, 1993, Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification, Am J Pathol, 143, 1543

McCall, 1991, Programmed cell death in terminally differentiating keratinocytes: role of endogenous endonuclease, J Invest Dermatol, 97, 111, 10.1111/1523-1747.ep12478519

Lumerman, 1995, Oral epithelial dysplasia and the development of invasive squamous cell carcinoma, Oral Surg Oral Med Oral Pathol, 79, 321, 10.1016/S1079-2104(05)80226-4

Voravud, 1993, Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis, Cancer Res, 53, 2874

Ogden, 1992, Assessment of p53 protein expression in normal, benign, and malignant oral mucosa, J Pathol, 166, 389, 10.1002/path.1711660411

Huang, 1994, Histopathologic evaluation of proliferating cell nuclear antigen (PC 10) in oral epithelial hyperplasias and premalignant lesions, Oral Surg Oral Med Oral Pathol, 78, 748, 10.1016/0030-4220(94)90091-4

Bronner, 1995, The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model, Am J Pathol, 146, 20

Lauwers, 1994, Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia, Cancer, 73, 2900, 10.1002/1097-0142(19940615)73:12<2900::AID-CNCR2820731205>3.0.CO;2-0